“Niche Busters” are New Frontier in Treatment at CU Cancer Center

Access to quality treatment can mean the difference between life and death for the more than 24,000 people in Colorado expected to be diagnosed with cancer this year.

New and experimental drugs are extending the lives of people with the deadliest forms of cancer. At the University of Colorado Cancer Center in Aurora, Dr. Ross Camidge leads clinical trials for lung cancer, which kills more people each year than breast cancer, colon cancer and pancreatic cancer combined.

Camidge calls them “niche-busters” – targeted therapies that dig deep into the profiles of each individual cancer. Researchers have discovered that just as individual patients have different genetic make-ups, so do their tumors.

Leave a Reply

Your email address will not be published. Required fields are marked *